{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T03:35:08.83096+00:00","published_at":"2026-10-16T13:52:46.314178+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:seat_on:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:5:company:28d94261-3731-4dc8-8b8e-dda37afdad32","relationship_type":"seat_on","from_id":"alpha:person:alison-moore-ph-d","to_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","from_label":"Alison Moore, Ph.D.","to_label":"Artiva Biotherapeutics, Inc.","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:6:company:28d94261-3731-4dc8-8b8e-dda37afdad32","relationship_type":"seat_on","from_id":"alpha:person:brian-daniels-m-d","to_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","from_label":"Brian Daniels, M.D.","to_label":"Artiva Biotherapeutics, Inc.","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:7:company:28d94261-3731-4dc8-8b8e-dda37afdad32","relationship_type":"seat_on","from_id":"alpha:person:daniel-baker-ph-d","to_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","from_label":"Daniel Baker, Ph.D.","to_label":"Artiva Biotherapeutics, Inc.","valid_from":"2025-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:8:company:28d94261-3731-4dc8-8b8e-dda37afdad32","relationship_type":"seat_on","from_id":"alpha:person:diego-miralles-m-d","to_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","from_label":"Diego Miralles, M.D.","to_label":"Artiva Biotherapeutics, Inc.","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:9:company:28d94261-3731-4dc8-8b8e-dda37afdad32","relationship_type":"seat_on","from_id":"alpha:person:elizabeth-hougen","to_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","from_label":"Elizabeth Hougen","to_label":"Artiva Biotherapeutics, Inc.","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:10:company:28d94261-3731-4dc8-8b8e-dda37afdad32","relationship_type":"seat_on","from_id":"alpha:person:fred-aslan-m-d","to_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","from_label":"Fred Aslan, M.D.","to_label":"Artiva Biotherapeutics, Inc.","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:11:company:28d94261-3731-4dc8-8b8e-dda37afdad32","relationship_type":"seat_on","from_id":"alpha:person:laura-stoppel-ph-d","to_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","from_label":"Laura Stoppel, Ph.D.","to_label":"Artiva Biotherapeutics, Inc.","valid_from":"2020-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:12:company:28d94261-3731-4dc8-8b8e-dda37afdad32","relationship_type":"seat_on","from_id":"alpha:person:yong-jun-huh","to_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","from_label":"Yong-Jun Huh","to_label":"Artiva Biotherapeutics, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"candidate","claim_id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:13:company:28d94261-3731-4dc8-8b8e-dda37afdad32","relationship_type":"executive_of","from_id":"alpha:person:christopher-p-horan","to_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","from_label":"Christopher P. Horan","to_label":"Artiva Biotherapeutics, Inc.","valid_from":"2025-04-29","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:49a37cc3389be89f458b58ee5db7c12ead68f56520f3775cd0962b065313aab0"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:14:company:28d94261-3731-4dc8-8b8e-dda37afdad32","relationship_type":"executive_of","from_id":"alpha:person:fred-aslan-m-d","to_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","from_label":"Fred Aslan, M.D.","to_label":"Artiva Biotherapeutics, Inc.","valid_from":"2025-04-29","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:14","evidence_ids":["alpha:projection-evidence:document:b0552ed2b752aeab85caefe6a60c553e7af5caa463fd1af30db554cd484b13f4"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:15:company:28d94261-3731-4dc8-8b8e-dda37afdad32","relationship_type":"executive_of","from_id":"alpha:person:heather-raymon-ph-d","to_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","from_label":"Heather Raymon, Ph.D.","to_label":"Artiva Biotherapeutics, Inc.","valid_from":"2025-04-29","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:15","evidence_ids":["alpha:projection-evidence:document:de182977583a51fd2c9fd5ba25ca90661a3e1c0a4dde16b15f505adda85310d7"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:16:company:28d94261-3731-4dc8-8b8e-dda37afdad32","relationship_type":"executive_of","from_id":"alpha:person:jennifer-bush","to_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","from_label":"Jennifer Bush","to_label":"Artiva Biotherapeutics, Inc.","valid_from":"2025-04-29","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:16","evidence_ids":["alpha:projection-evidence:document:77659bafedc6e5c913c482dc6836adb367a41852660755b1d31ff448c335015b"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:17:company:28d94261-3731-4dc8-8b8e-dda37afdad32","relationship_type":"executive_of","from_id":"alpha:person:neha-krishnamohan","to_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","from_label":"Neha Krishnamohan","to_label":"Artiva Biotherapeutics, Inc.","valid_from":"2025-04-29","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:17","evidence_ids":["alpha:projection-evidence:document:427131549f36eaf30a00009bf9306e06317ac17bc0c24d2d25b580bf8381043c"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:18:company:28d94261-3731-4dc8-8b8e-dda37afdad32","relationship_type":"executive_of","from_id":"alpha:person:subhashis-banerjee-m-d","to_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","from_label":"Subhashis Banerjee, M.D.","to_label":"Artiva Biotherapeutics, Inc.","valid_from":"2025-04-29","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:18","evidence_ids":["alpha:projection-evidence:document:43d76b5685f017fa9af49b1583fba8c340392541d87fed70966834ccb0b313f2"]}]},"claims":[{"id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:5","subject_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:alison-moore-ph-d","object_label":"Alison Moore, Ph.D.","object_source_name_forms":[],"value":"Alison Moore, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:alison-moore-ph-d","name":"Alison Moore, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:46.314178+00:00","sources":[{"id":"alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Artiva Biotherapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:33:02.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:6","subject_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:brian-daniels-m-d","object_label":"Brian Daniels, M.D.","object_source_name_forms":[],"value":"Brian Daniels, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:brian-daniels-m-d","name":"Brian Daniels, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:46.314178+00:00","sources":[{"id":"alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Artiva Biotherapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:33:02.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:7","subject_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:daniel-baker-ph-d","object_label":"Daniel Baker, Ph.D.","object_source_name_forms":[],"value":"Daniel Baker, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:daniel-baker-ph-d","name":"Daniel Baker, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:46.314178+00:00","sources":[{"id":"alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Artiva Biotherapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:33:02.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:8","subject_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:diego-miralles-m-d","object_label":"Diego Miralles, M.D.","object_source_name_forms":[],"value":"Diego Miralles, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:diego-miralles-m-d","name":"Diego Miralles, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:46.314178+00:00","sources":[{"id":"alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Artiva Biotherapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:33:02.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:9","subject_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:elizabeth-hougen","object_label":"Elizabeth Hougen","object_source_name_forms":[],"value":"Elizabeth Hougen: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:elizabeth-hougen","name":"Elizabeth Hougen"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:46.314178+00:00","sources":[{"id":"alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Artiva Biotherapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:33:02.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:10","subject_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:fred-aslan-m-d","object_label":"Fred Aslan, M.D.","object_source_name_forms":[],"value":"Fred Aslan, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:fred-aslan-m-d","name":"Fred Aslan, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:46.314178+00:00","sources":[{"id":"alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Artiva Biotherapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:33:02.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:11","subject_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:laura-stoppel-ph-d","object_label":"Laura Stoppel, Ph.D.","object_source_name_forms":[],"value":"Laura Stoppel, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:laura-stoppel-ph-d","name":"Laura Stoppel, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T13:52:46.314178+00:00","sources":[{"id":"alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Artiva Biotherapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:33:02.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:12","subject_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:yong-jun-huh","object_label":"Yong-Jun Huh","object_source_name_forms":[],"value":"Yong-Jun Huh: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:yong-jun-huh","name":"Yong-Jun Huh"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":null,"start_date":null,"end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T13:52:46.314178+00:00","sources":[{"id":"alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Artiva Biotherapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:33:02.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":null,"effective_until":null,"observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:13","subject_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:christopher-p-horan","object_label":"Christopher P. Horan","object_source_name_forms":[],"value":"Christopher P. Horan: Chief Technical Operations Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:christopher-p-horan","name":"Christopher P. Horan"},"title":"Chief Technical Operations Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-04-29","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-04-29","valid_to":null,"recorded_at":"2026-10-16T13:52:46.314178+00:00","sources":[{"id":"alpha:projection-evidence:document:49a37cc3389be89f458b58ee5db7c12ead68f56520f3775cd0962b065313aab0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:56:31.718818+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29T00:00:00+00:00","effective_from":"2025-04-29","effective_until":null,"observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:14","subject_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:fred-aslan-m-d","object_label":"Fred Aslan, M.D.","object_source_name_forms":[],"value":"Fred Aslan, M.D.: President, Chief Executive Officer and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:fred-aslan-m-d","name":"Fred Aslan, M.D."},"title":"President, Chief Executive Officer and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-04-29","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-04-29","valid_to":null,"recorded_at":"2026-10-16T13:52:46.314178+00:00","sources":[{"id":"alpha:projection-evidence:document:b0552ed2b752aeab85caefe6a60c553e7af5caa463fd1af30db554cd484b13f4","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:56:30.402099+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29T00:00:00+00:00","effective_from":"2025-04-29","effective_until":null,"observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:15","subject_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:heather-raymon-ph-d","object_label":"Heather Raymon, Ph.D.","object_source_name_forms":[],"value":"Heather Raymon, Ph.D.: Senior Vice President of Research and Early Development","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:heather-raymon-ph-d","name":"Heather Raymon, Ph.D."},"title":"Senior Vice President of Research and Early Development","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-04-29","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-04-29","valid_to":null,"recorded_at":"2026-10-16T13:52:46.314178+00:00","sources":[{"id":"alpha:projection-evidence:document:de182977583a51fd2c9fd5ba25ca90661a3e1c0a4dde16b15f505adda85310d7","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:56:32.550458+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29T00:00:00+00:00","effective_from":"2025-04-29","effective_until":null,"observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:16","subject_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:jennifer-bush","object_label":"Jennifer Bush","object_source_name_forms":[],"value":"Jennifer Bush: Chief Operating Officer, Chief Legal Officer, Corporate Secretary and Compliance Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:jennifer-bush","name":"Jennifer Bush"},"title":"Chief Operating Officer, Chief Legal Officer, Corporate Secretary and Compliance Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-04-29","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-04-29","valid_to":null,"recorded_at":"2026-10-16T13:52:46.314178+00:00","sources":[{"id":"alpha:projection-evidence:document:77659bafedc6e5c913c482dc6836adb367a41852660755b1d31ff448c335015b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:56:31.262798+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29T00:00:00+00:00","effective_from":"2025-04-29","effective_until":null,"observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:17","subject_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:neha-krishnamohan","object_label":"Neha Krishnamohan","object_source_name_forms":[],"value":"Neha Krishnamohan: Chief Financial Officer and Executive Vice President of Corporate Development","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:neha-krishnamohan","name":"Neha Krishnamohan"},"title":"Chief Financial Officer and Executive Vice President of Corporate Development","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-04-29","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-04-29","valid_to":null,"recorded_at":"2026-10-16T13:52:46.314178+00:00","sources":[{"id":"alpha:projection-evidence:document:427131549f36eaf30a00009bf9306e06317ac17bc0c24d2d25b580bf8381043c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:56:32.060258+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29T00:00:00+00:00","effective_from":"2025-04-29","effective_until":null,"observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:28d94261-3731-4dc8-8b8e-dda37afdad32:leadership_role:18","subject_id":"alpha:company:28d94261-3731-4dc8-8b8e-dda37afdad32","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:subhashis-banerjee-m-d","object_label":"Subhashis Banerjee, M.D.","object_source_name_forms":[],"value":"Subhashis Banerjee, M.D.: Chief Medical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:subhashis-banerjee-m-d","name":"Subhashis Banerjee, M.D."},"title":"Chief Medical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-04-29","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-04-29","valid_to":null,"recorded_at":"2026-10-16T13:52:46.314178+00:00","sources":[{"id":"alpha:projection-evidence:document:43d76b5685f017fa9af49b1583fba8c340392541d87fed70966834ccb0b313f2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:56:30.875791+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29T00:00:00+00:00","effective_from":"2025-04-29","effective_until":null,"observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:3046284bf0584fcb73a512109acc11ee3188e7ab689e5fa2504be71c6e25c380","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Artiva Biotherapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:33:02.896+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:49a37cc3389be89f458b58ee5db7c12ead68f56520f3775cd0962b065313aab0","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:56:31.718818+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b0552ed2b752aeab85caefe6a60c553e7af5caa463fd1af30db554cd484b13f4","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:56:30.402099+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:de182977583a51fd2c9fd5ba25ca90661a3e1c0a4dde16b15f505adda85310d7","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:56:32.550458+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:77659bafedc6e5c913c482dc6836adb367a41852660755b1d31ff448c335015b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:56:31.262798+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:427131549f36eaf30a00009bf9306e06317ac17bc0c24d2d25b580bf8381043c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:56:32.060258+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:43d76b5685f017fa9af49b1583fba8c340392541d87fed70966834ccb0b313f2","identity_scope":"source_document_reference","source_type":"sec_filing","title":"ARTV DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1817241/000119312525101364/d104082ddef14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-15T22:56:30.875791+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.85,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.856,"cross_source_agreement":0.75,"temporal_completeness":0.929},"diagnostics":{"published_claims":18,"factual_claims":18,"claims_with_linked_evidence":18,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":14,"temporal_claims_with_valid_from":13,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","committee","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T13:52:46.314178+00:00","observed_at":"2026-10-16T13:52:46.314178+00:00","reviewed_at":"2026-10-16T13:52:46.314178+00:00","verified_at":"2026-10-16T13:52:46.314178+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":18,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/artiva-biotherapeutics-inc/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/artiva-biotherapeutics-inc?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}